OrthoPediatrics Corp. Announces 2024 Annual Meeting of Stockholders

TL;DR

<b>OrthoPediatrics Corp. will hold its 2024 Annual Meeting on May 24, 2024, to elect directors, approve executive compensation, and ratify auditor appointment.</b>

AI Summary

ORTHOPEDIATRICS CORP (KIDS) filed a Proxy Statement (DEF 14A) with the SEC on April 8, 2024. The 2024 annual meeting of OrthoPediatrics Corp. stockholders will be held on May 24, 2024. Key agenda items include electing three directors, approving executive compensation, and ratifying the 2024 Incentive Award Plan. Stockholders will also vote on the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2024. The record date for determining stockholders entitled to vote is April 4, 2024. Proxy materials will be delivered over the Internet, with a Notice of Internet Availability sent on or about April 12, 2024.

Why It Matters

For investors and stakeholders tracking ORTHOPEDIATRICS CORP, this filing contains several important signals. The meeting agenda includes critical corporate governance matters such as director elections and executive compensation approval, which directly impact shareholder value and company direction. The proposed 2024 Incentive Award Plan and the ratification of Deloitte & Touche LLP as auditor are key to ensuring continued operational effectiveness and financial integrity.

Risk Assessment

Risk Level: — ORTHOPEDIATRICS CORP shows moderate risk based on this filing. The filing is a routine proxy statement (DEF 14A) and does not contain new financial performance data or strategic shifts, indicating a low-risk informational update.

Analyst Insight

Stockholders should review the proxy materials carefully to understand the proposals and cast their votes on director elections, executive compensation, and auditor ratification.

Key Numbers

• May 24, 2024 — Annual Meeting Date (2024 annual meeting of stockholders)
• April 4, 2024 — Record Date (close of business on April 4, 2024)
• April 12, 2024 — Notice Mailing Date (On or about April 12, 2024)

Key Players & Entities

• ORTHOPEDIATRICS CORP (company) — Registrant
• Deloitte & Touche LLP (company) — independent registered public accounting firm
• May 24, 2024 (date) — annual meeting date
• April 4, 2024 (date) — record date
• April 12, 2024 (date) — Notice of Internet Availability mailing date

FAQ

Risk Factors

• Proxy Statement Filing [low — regulatory]: This filing is a definitive proxy statement (DEF 14A) filed under Section 14(a) of the Securities Exchange Act of 1934.

Industry Context

OrthoPediatrics Corp. operates in the surgical and medical instruments and apparatus industry, focusing on pediatric orthopedics.

Regulatory Implications

The filing is made in accordance with Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.

What Investors Should Do

1. Review the proxy statement for details on director nominees and their qualifications.
2. Evaluate the proposed 2024 Incentive Award Plan and its potential impact on shareholder value.
3. Consider the appointment of Deloitte & Touche LLP as the independent auditor and vote accordingly.

Key Dates

• 2024-05-24: Annual Meeting of Stockholders — Election of directors, advisory vote on executive compensation, approval of incentive award plan, and advisory vote on auditor appointment.
• 2024-04-04: Record Date — Determines stockholders entitled to vote at the annual meeting.
• 2024-04-12: Notice of Internet Availability of Proxy Materials — Informs stockholders how to access proxy materials and vote.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard proxy statement for an upcoming annual meeting. No prior filing is referenced for comparison in this extract.

Key Financial Figures

• $3 billion — eneral Counsel for Healthcare Law for a $3 billion leader in post-acute healthcare service

Filing Documents

• kids2024proxy.htm (DEF 14A) — 492KB
• chart-12faf280a7a04c4f867.jpg (GRAPHIC) — 27KB
• chart-67f93c62f8304294918.jpg (GRAPHIC) — 29KB
• chart-6d3fa342398943f294b.jpg (GRAPHIC) — 69KB
• chart-87d21eebfd2145f58b3.jpg (GRAPHIC) — 67KB
• chart-c3bed749e6cb4b46ace.jpg (GRAPHIC) — 74KB
• chart-e2f1a38ada854cb1ac6.jpg (GRAPHIC) — 31KB
• chart-e5cf5d2cf99b4665b0b.jpg (GRAPHIC) — 30KB
• gerritzendaniela01.jpg (GRAPHIC) — 21KB
• oplogoinnovationtaga02.jpg (GRAPHIC) — 681KB
• 0001425450-24-000027.txt (&nbsp;) — 1909KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 15 Executive Officer and Director Compensation 18 Proposal 2 - Advisory Vote on Executive Compensation 26 Proposal 3 - Vot e on t he C ompany's 2024 Incentive A ward P la n 27 Report of the Audit Committee 35 Certain Relationships and Related Party Transactions 36 Proposal 4 – Advisory Vote on the Approval of the Appointment of Independent Registered Public Accounting Firm 37 Section 16(a) Beneficial Ownership Reporting Compliance 38 Stockholder Proposals For 2024 Annual Meeting 38 Annual Report 40 PROXY STATEMENT ANNUAL MEETING OF STOCKHOLDERS OF ORTHOPEDIATRICS CORP. to be held May 24, 2024 INTRODUCTION The Board of Directors of OrthoPediatrics Corp. is soliciting proxies from stockholders for its use at the 2024 annual meeting of stockholders, and at any adjournment or adjournments of that meeting. The annual meeting is scheduled to be held on May 24, 2024, at 1130 a.m., Eastern Time, at The St. Louis Club, 7676 Forsyth Blvd., St. Louis, Missouri 63105. To improve readability, OrthoPediatrics Corp., which has prepared this proxy statement, will sometimes speak in this document in the first-person (using words such as "we" or "our" or "us") and will address its stockholders using second-person words (such as "you" or "your"). We will also sometimes refer to OrthoPediatrics Corp., as "the Company." References to the Board of Directors of the Company in this proxy statement will usually be shortened to "our Board." References to our "Proxy Committee" will refer to David R. Bailey and Bryan W. Hughes, who are designated by the proxy cards that accompany this proxy statement as being the persons who are authorized to vote at the annual meeting those shares that are owned of record by stockholders that sign and return such proxy cards. This proxy statement relates to the solicitation of proxies by our Board of Directors for use at the annual meeting. On or about April 1

View Full Filing

View this DEF 14A filing on SEC EDGAR